LAIVs with completely deleted NS1 (known as delta-NS1 LAIVs) have been assessed in 160 volunteer recipients in four clinical trials directed at the Medical University of Vienna by AVIR Green Hills Biotechnology.
The considerable achievements by AVIR Green Hills in the development, cell-based manufacture and clinical evaluation of delta-NS1 LAIVs, combined with Vivaldi s technology platform and programs, give us a range of NS1 technology based approaches for LAIVs for these significant unmet needs .
The AVIR project has developed routines that create this kind of content-description automatically.
The new technologies are shown in a demonstration set-up developed within the AVIR project.
The technologies developed in the AVIR project illustrate options for the next generation of Personal TV applications.
Dr Rick Harwig, Managing Director of Philips Research Laboratories in Eindhoven adds: "The AVIR consumer system helps people at home to cope with the increasing information overload they encounter.
More information about AVIR is available at http://www.
A representative list of companies reviewed in the report include: (by stock symbol), ABT, ALKS, AMGN, DNA, BGEN, CHIR, GENZ, GILD, MEDI, MEDX, PDLI, TRMS, CTIC, CVTX, IMCL, MEDX, INHL, MYL, KG, WPI, CALP, CYTC, DP, CLTX, HGSI, VICL, CRA, AVGN, INCY, BRL, ADRX, CRGN, MLMN, HYSQ, MYGN, ORCH, AGN, AZN, GLX, MRK, BMY, AVE, PFE, PHA, ABSC, AVIR
, CRXA, ENZN, LLY, SGP, AZA, ELN, ALXN, SEPR, TTP, CVD, QTRN, BVF, TECH, CAH, ALO.